Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Regulatory News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

Share Price is delayed by 15 minutes
Get Live Data
1,543.00    19.00 (1.25%)
Bid:
1,542.00
Ask:
1,544.00
Spread: 2.00 (0.13%)
Market Cap: £3.25b
HIK Live PriceLast checked at - London Stock Exchange

Intraday Hikma Pharmaceuticals Share Chart

LTIP Awards

30 Apr 2008 15:22

Hikma Pharmaceuticals Plc30 April 2008 Hikma Pharmaceuticals PLC - LTIP Awards LONDON, 30 April 2008: Hikma Pharmaceuticals PLC (LSE: HIK) (DIFX: HIK)announces that the Remuneration Committee has made the following nil-cost awardsunder the Hikma Pharmaceuticals PLC 2005 Long-Term Incentive Plan (the "LTIP")to Directors and Persons Discharging Managerial Responsibility ("PDMRs") of theCompany. Awards under the LTIP were made on 29 April 2008 at a price of £4.64 perordinary share as follows:- Name of Director/PDMR Number of LTIP SharesSaid Darwazah 90,000Mazen Darwazah 54,000Bassam Kanaan 54,000Taghreed Al-Shunnar 54,000Majda Labadi 54,000Nabil Rizk 54,000 The shares subject to the LTIP awards will only be released to the participantsin three years time, subject to their continued employment and the satisfactionof the comparative Total Shareholder Return ("TSR") performance target.Participants will only receive the full benefit of their share incentives if TSRperformance against the Comparator Group is at least at the upper quartile. - ENDS -Enquiries: Hikma Pharmaceuticals PLCHenry Knowles +44 20 7399 2760Company Secretary Susan Ringdal +44 20 7399 2760Investor Relations Director About Hikma Hikma Pharmaceuticals PLC is a fast growing multinational group focused ondeveloping, manufacturing and marketing a broad range of both branded andnon-branded generic and in-licensed pharmaceutical products. Hikma's operationsare conducted through three businesses: "Branded", "Injectables" and"Generics". Hikma's operations are based principally in the Middle East andNorth Africa ("MENA") region, where it is a market leader and sells across 17countries, the United States and Europe. In 2007, the Group achieved revenuesof $449 million (2006 $317 million) and profit attributable to shareholders was$63 million (2006 $55 million). For news and other information, please visitwww.hikma.com. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
12th Jan 201110:13 amRNSDirector/PDMR Shareholding
10th Jan 20113:47 pmRNSDirector/PDMR Shareholding
10th Jan 201111:51 amRNSDirector/PDMR Shareholding
5th Jan 201111:32 amRNSTotal Voting Rights
16th Dec 20105:27 pmRNSDirector/PDMR Shareholding
6th Dec 20104:29 pmRNSDirector/PDMR Shareholding
1st Dec 20104:18 pmRNSDirector/PDMR Shareholding
12th Nov 20107:00 amRNSInterim Management Statement
9th Nov 20109:48 amRNSDirector/PDMR Shareholding
5th Nov 20103:37 pmRNSTotal Voting Rights
4th Nov 20104:15 pmRNSDirector/PDMR Shareholding
2nd Nov 201010:42 amRNSDirector/PDMR Shareholding
29th Oct 20107:00 amRNSAcquisition
18th Oct 20107:00 amRNSProduct Update
15th Oct 201011:10 amRNSBlock Listing for Share Schemes
4th Oct 20105:18 pmRNSTotal Voting Rights
4th Oct 20105:04 pmRNSBlocklisting Interim Review
1st Oct 20107:00 amRNSCompany Update
6th Sep 20103:53 pmRNSTotal Voting Rights
26th Aug 20107:00 amRNSInterim Results
4th Aug 20105:19 pmRNSVoting Rights and Capital
2nd Aug 201012:16 pmRNSAnnual Information Update
26th Jul 20105:30 pmRNSVoting Rights and Capital
13th May 20103:37 pmRNSAGM Statement
13th May 20107:00 amRNSInterim Management Statement
5th May 20105:48 pmRNSVoting Rights & Capital
23rd Apr 20103:16 pmRNSDirector/PDMR Shareholding
20th Apr 201010:02 amRNSDirector/PDMR Shareholding
12th Apr 20109:14 amRNSHikma expands in the Algerian market
9th Apr 20104:33 pmRNSAnnual Financial Report
9th Apr 201012:50 pmRNSDirector/PDMR Shareholding
9th Apr 201012:48 pmRNSDirector/PDMR Shareholding
8th Apr 201010:13 amRNSDirector/PDMR Shareholding
7th Apr 20107:00 amRNSHikma & CellTrion enter an exclusive partnership
7th Apr 20107:00 amRNSDirector/PDMR Shareholding
1st Apr 201012:23 pmRNSVoting Rights & Capital
1st Apr 201012:10 pmRNSBlocklisting Six Monthly return
30th Mar 20109:20 amRNSHikma expands in the Tunisian market
23rd Mar 20104:18 pmRNSDirector/PDMR Shareholding
17th Mar 20107:00 amRNSPreliminary Announcement for 2009
15th Mar 20109:43 amRNSBlocklisting of Shares
10th Mar 201011:00 amRNSTotal Voting Rights
1st Mar 20105:51 pmRNSNotice of Results
1st Feb 20101:40 pmRNSTotal Voting Rights
11th Jan 201012:00 pmRNSNon Regulatory Announcement
5th Jan 20102:10 pmRNSDirector/PDMR Shareholding
4th Jan 20106:28 pmRNSTotal Voting Rights
18th Dec 20093:17 pmRNSDirector/PDMR Shareholding
1st Dec 200910:05 amRNSTotal Voting Rights
1st Dec 200910:03 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.